Yes, infectious mononucleosis is caused by Epstein-Barr virus (EBV).
EBV is the primary causative agent of infectious mononucleosis (IM), accounting for the vast majority of cases 1, 2. This is well-established in both guideline literature and clinical practice.
Understanding the Relationship
The evidence consistently demonstrates that:
- EBV directly causes IM through primary infection, typically presenting with the classic triad of fever, tonsillar pharyngitis, and lymphadenopathy 3
- EBV is one of eight known human herpesviruses and is ubiquitous, with IM being one of its most common symptomatic manifestations 1
- Over 90% of the normal adult population has IgG antibodies to EBV antigens, indicating prior infection 2
Important Clinical Distinctions
While EBV causes most IM cases, other pathogens can produce a mononucleosis-like syndrome:
- Cytomegalovirus (CMV) is the second most common cause of IM-like illness 4, 5
- Other rare causes include HIV (acute infection), Toxoplasma gondii, and adenovirus 2, 5
When the heterophile antibody test (Monospot) is negative—which occurs in approximately 10% of patients, especially children under 10 years—specific EBV serologic testing should be performed to differentiate true EBV-IM from other causes 2.
Diagnostic Approach
For suspected IM:
- Initial testing: Heterophile antibody (Monospot) test becomes detectable between days 6-10 after symptom onset 2
- If negative: Order EBV-specific antibodies (VCA IgM, VCA IgG, and EBNA) 2
- Diagnostic pattern for acute EBV: VCA IgM present (with or without VCA IgG) in the absence of EBNA antibodies indicates recent primary EBV infection 2
The presence of EBNA antibodies indicates infection occurred more than 6 weeks prior and makes EBV an unlikely cause of current symptoms 2.
Clinical Pitfalls
- False-positive heterophile tests can occur with leukemia, pancreatic carcinoma, viral hepatitis, or CMV infection 2
- False-negative heterophile tests are common in young children 2
- CMV-IM patients tend to be approximately 10 years older than EBV-IM patients and have a longer interval from symptom onset to presentation 4